Recursion Announces Transformational Collaboration with Roche and Genentech in Neuroscience and Oncology, Advancing Novel Medicines to Patients Using Machine Learning and High Content Screening Methods at Scale to Map Complex BiologyPRNewsWire • 12/07/21
Recursion and Bayer Expand Fibrosis Collaboration to Include Inferential Search CapabilitiesPRNewsWire • 12/06/21
Recursion Enhances its Leadership Team and Deepens Focus on Neuroscience with Three Senior AppointmentsPRNewsWire • 11/30/21
Recursion is Granted FDA Fast Track Designation for REC-2282 for the Potential Treatment of NF2-Mutated MeningiomasPRNewsWire • 10/07/21
Recursion is Granted Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous PolyposisPRNewsWire • 09/29/21
Recursion Announces Therapeutics Advisory Board, Chaired by Joseph Miletich, MD, PhDPRNewsWire • 07/13/21
Recursion Signs Lease With Vestar for an Additional 100,000 sf of Space at the Gateway in Downtown Salt Lake CityPRNewsWire • 07/01/21
Recursion Announces Multi-Year Collaboration with Mila for Tech-Enabled Drug DiscoveryPRNewsWire • 06/23/21
Recursion Announces its First Major Multidisciplinary Expansion, in Toronto, to Further Tech-Enabled Drug DiscoveryPRNewsWire • 06/15/21
Recursion Announces First Internally-Developed NCE Advanced to IND-Enabling Studies to Potentially Treat Clostridium difficile ColitisPRNewsWire • 05/25/21
